ELVN NASDAQ
Enliven Therapeutics, Inc.
1W: -1.9%
1M: -4.9%
3M: +62.4%
YTD: +171.9%
1Y: +143.1%
3Y: +113.2%
5Y: +31.2%
$41.54
-0.71 (-1.68%)
Weekly Expected Move ±6.0%
$36
$39
$41
$44
$46
Overview
News
Chart
Smart Money
Financials
Income Statement
Cash Flow
Balance Sheet
Earnings
Dividends
Analysis
Technicals
Weather
Peers
ESG
Institutions
ETF Exposure
Dark Pool
Short Interest
Supply Chain
📊 Key Metrics
TTM$0M
Revenue
+0.0% YoY
$-99M
Net Income
-4.2% YoY
$-66M
Free Cash Flow
+11.3% YoY
0.0%
Gross Margin
0.0%
Op. Margin
0.0%
Net Margin
💰 Income Flow
How revenue becomes profit💵 Cash Flow
⚠️ Cash Burn Where cash goes🏦 Balance Sheet
Assets = Liabilities + Equity📈 Financial Health
Profitability
ROE-25.7%
ROA-24.6%
ROIC3488.7%
Valuation
P/E-26.4
P/B5.8
EV/EBITDA-18.1
Leverage
Debt/Equity0.00
Current Ratio28.66
Interest Cov.0.0x
Quality Scores
Piotroski F4/9
Altman Z87.94
Beneish M0.00